ApprovalTrail

Approval · Notice of Compliance 4675 · 1996

INTRALIPID: Notice of Compliance 4675

Issued March 14, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4675
Date
March 14, 1996
Company
Pharmacia Inc.Mississauga, Ontario, Canada
Product type
Nonprescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Provides for a new strength: a more concentrated product
Therapeutic class
Fat emulsion for intravenous nutrition

Products in this notice

BrandDINStatus today
INTRALIPID02216175Dormant

Medicinal ingredients